Physician-collected | Self-collected | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Cutoff Pointa | Positive case of CIN2- | Positive case of CIN3+ | Sensitivity (95 % CI) | Specificity (95 % CI) | Positive in CIN2- | Positive in CIN3+ | Sensitivity (95 % CI) | Specificity (95 % CI) | P b |
(Total, N = 70) | (Total, N = 66) | (Total N = 70) | (Total N = 66) | |||||||
PAX 1 | 0.014 | 16 | 42 | 0.64 | 0.77 | 17 | 40 | 0.61 | 0.76 | 0.81 |
(22.86Â %) | (64.64Â %) | (0.51 to 0.75) | (0.66 to 0.86) | (24.3Â %) | (60.6Â %) | (0.48 to 0.72) | (0.64 to 0.85) | |||
SOX1 | 0.156 | 18 | 49 | 0.74 | 0.74 | 25 | 51 | 0.77 | 0.64 | 0.81 |
(25.71Â %) | (74.24Â %) | (0.62 to 0.84) | (0.62 to 0.84) | (35.7Â %) | (77.3Â %) | (0.65 to 0.87) | (0.52 to 0.75) | |||
ZNF582 | 0.214 | 12 | 40 | 0.61 | 0.83 | 9 | 42 | 0.64 | 0.87 | 0.81 |
(17.14Â %) | (60.61Â %) | (0.48 to 0.72) | (0.72 to 0.91) | (12.9Â %) | (63.6Â %) | (0.51 to 0.75) | (0.77 to 0.94) | |||
Any of SOX1, PAX1 | Â | 25 | 53 | 0.80 | 0.64 | 32 | 53 | 0.80 | 0.54 | 1.00 |
(35.71Â %) | (80.3Â %) | (0.69 to 0.89) | (0.52 to 0.75) | (44.7Â %) | (80.3Â %) | (0.69 to 0.89) | (0.42 to 0.66) | |||
Any of SOX1, ZNF582 | Â | 22 | 53 | 0.80 | 0.69 | 27 | 53 | 0.80 | 0.61 | 1.00 |
(31.4Â %) | (80.3Â %) | (0.69 to 0.89) | (0.56 to 0.79) | (38.6Â %) | (80.3Â %) | (0.69 to 0.89) | (0.49 to 0.73) | |||
Any of PAX1, ZNF582 | Â | 23 | 48 | 0.73 | 0.67 | 20 | 48 | 0.73 | 0.71 | 1.00 |
(32.9Â %) | (72.7Â %) | (0.60 to 0.83) | (0.55 to 0.78) | (28.6Â %) | (72.7Â %) | (0.60 to 0.83) | (0.59 to 0.82) | |||
Any one of three | Â | 29 | 57 | 0.86 | 0.59 | 34 | 55 | 0.83 | 0.51 | 0.75 |
(41.4Â %) | (86.4Â %) | (0.76 to 0.94) | (0.46 to 0.70) | (48.6Â %) | (83.3Â %) | (0.72 to 0.91) | (0.39 to 0.64) | |||
Any two of three | Â | 12 | 40 | 0.71 | 0.83 | 11 | 44 | 0.67 | 0.84 | 0.52 |
(17.1Â %) | (60.6Â %) | (0.48 to 0.72) | (0.72 to 0.91) | (15.7Â %) | (66.7Â %) | (0.5 to 0.78) | (0.74 to 0.92) |